Stay updated on OMS721 in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.
Latest updates to the OMS721 in IgA Nephropathy Clinical Trial page
- Check6 days agoChange DetectedResults were posted indicating the primary endpoint was not met and the trial was terminated. The page now includes the termination status, results submission dates, and related study details.SummaryDifference2%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note clarifying that publications are automatically filled from PubMed and may not all pertain to the study, and updated the revision label to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check27 days agoChange DetectedRemoval of the government funding status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check49 days agoChange DetectedNo significant changes detected between the two screenshots of the study details page; the content and structure appear unchanged.SummaryDifference0.2%
- Check70 days agoChange DetectedUpdated page now publicly states funding-related operational notices and current version (v3.2.0), while removing a prior resource entry (IgA glomerulonephritis) and referencing the newer revision.SummaryDifference3%
- Check78 days agoChange DetectedContent taxonomy update: broad saline/solution terms are removed and specific chemical categories and Sodium Chloride-related entries are added, with a version bump from v3.0.2 to v3.1.0.SummaryDifference0.6%
Stay in the know with updates to OMS721 in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.